This protocol is judged by an institutional evaluation board, an independent group that critiques any scientific trials involving human beings. If a review requires a Schedule I drug, after the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) amount in the FDA.He said he apprecia